Human Alveolar Macrophage-derived Chemotactic Factor for Neutrophils
Open Access
- 1 September 1980
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 66 (3) , 473-483
- https://doi.org/10.1172/jci109878
Abstract
The presence of neutrophils within the lung is a characteristic feature of a variety of lung diseases. To evaluate the potential role of alveolar macrophages in modulating the migration of neutrophils to the lung, normal human alveolar macrophages obtained from volunteers by bronchopulmonary lavage, were exposed for various periods of time in vitro to heat-killed microorganisms, and noninfectious particulates, immune complexes, and the macrophage supernates were evaluated for chemotactic activity. The microorganisms, noninfectious particulates, and immune complexes were chosen as stimuli for alveolar macrophages because these stimuli are representative of a spectrum of pathogenic agents that cause neutrophil accumulation in the lower respiratory tract. After incubation with each of these stimuli, alveolar macrophages released low molecular weight (400-600) chemotactic factor(s) (alveolar macrophage-derived chemotactic factor[s] [AMCF]) with relatively more activity for neutrophils than monocytes or eosinophils. Checker-board analysis of the AMCF revealed that the factor was primarily chemotactic and not chemokinetic for neutrophils. The selectivity for neutrophils vs. monocytes could not be explained by a selective deactivation of monocytes, because the AMCF was more potent in deactivating neutrophils than monocytes. Partial characterization of AMCF demonstrated it was heterogeneous with the following features: (a) stable to heating at 56 and 100°C for 30 min; (b) stable over a pH range of 1.0 to 12.0 for 60 min; (c) stable after exposure to trypsin, papain, chymotrypsin, collagenase, and elastase; (d) partially inhibited by serum chemotactic factor inhibitor(s); (e) two major isoelectric points (pI 7.6 and 5.2); and (f) partially extractable into ethyl acetate, ether, and hexane. Although AMCF was, at least, partially lipid in nature, it did not appear to be similar to previously described lipid chemotactic factors (e.g., hydroxy-derivatives of 5,8,10,14-eicosatetraenoic acid); analysis by gas chromatography-mass spectrophotometry of AMCF extracted into ethyl acetate did not reveal the presence of 5,8,10,14-eicosatetraenoic acid. The macrophage supernates containing the AMCF also stimulated normal human neutrophils to release lysozyme and lactoferrin but not lactate dehydrogenase. These studies suggest that a wide variety of potentially pathogenic stimuli induce normal alveolar macrophages to generate a low molecular weight chemotactic factor(s) that preferentially attracts neutrophils. Because alveolar macrophages are normal residents of alveoli, it is likely that by releasing this factor(s) macrophages play a significant role in amplifying the inflammatory processes seen in many acute and chronic lung diseases.This publication has 37 references indexed in Scilit:
- Maintenance of Granuloma Formation in Pulmonary Sarcoidosis by T Lymphocytes within the LungNew England Journal of Medicine, 1980
- Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.1979
- CHEMOTACTIC RESPONSE TO HUMAN C3A AND C5A ANAPHYLATOXINS .1. EVALUATION OF C3A AND C5A LEUKOTAXIS INVITRO AND UNDER SIMULATED INVIVO CONDITIONS1978
- Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.Journal of Clinical Investigation, 1977
- Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.Journal of Clinical Investigation, 1977
- Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathwaysClinical Immunology and Immunopathology, 1975
- Chemotactic Activity in Dialyzable Transfer FactorProceedings of the National Academy of Sciences, 1974
- The Fibrinolytic Pathway of Human Plasma II. THE GENERATION OF CHEMOTACTIC ACTIVITY BY ACTIVATION OF PLASMINOGEN PROACTIVATORJournal of Clinical Investigation, 1973
- C3 Shunt Activation in Human Serum Chelated with EGTAThe Journal of Immunology, 1972
- C5 Chemotactic Fragments Produced by an Enzyme in Lysosomal Granules of NeutrophilsThe Journal of Immunology, 1970